Neuberger Berman Group LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,249,484
+32.6%
39,132
+27.1%
0.00%0.0%
Q1 2023$942,514
-18.8%
30,781
+3.7%
0.00%0.0%
Q4 2022$1,161,254
+9.0%
29,692
+32.9%
0.00%0.0%
Q3 2022$1,065,000
+22.7%
22,349
-0.3%
0.00%0.0%
Q2 2022$868,000
-33.1%
22,421
-0.9%
0.00%0.0%
Q1 2022$1,297,000
-37.3%
22,629
-14.7%
0.00%
-50.0%
Q4 2021$2,069,000
-8.4%
26,529
-0.0%
0.00%0.0%
Q3 2021$2,258,000
-32.0%
26,533
+2.8%
0.00%
-33.3%
Q2 2021$3,319,00025,8080.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders